Spotless Management

Results

28

5 new

Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.

28 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	300476	CN¥279.39	18.2%	17.4%	CN¥267.8b	CN¥449.85	58.7	51.3%	0.7%	Tech
	600176 New	CN¥43.31	10.3%	247.6%	CN¥171.9b	CN¥63.05	45.0	32.5%	0.9%	Materials
	002028	CN¥165.89	3.1%	93.8%	CN¥129.8b	CN¥217.39	38.8	30.5%	0.4%	Capital Goods
	600489	CN¥25.56	5.4%	73.2%	CN¥123.9b	CN¥29.89	19.7	24.3%	1.8%	Materials
	605117	CN¥94.09	12.3%	136.9%	CN¥119.8b	CN¥139.21	32.8	26.1%	2.2%	Capital Goods
	600160	CN¥41.20	-4.4%	42.0%	CN¥111.2b	CN¥49.10	26.8	21.5%	1.4%	Materials
	002602 New	CN¥14.29	1.2%	1.6%	CN¥104.3b	CN¥23.52	16.6	20.9%	0.4%	Media
	600549	CN¥56.37	4.9%	136.4%	CN¥89.5b	CN¥77.80	29.5	21.3%	1.0%	Materials
	002709	CN¥39.46	1.0%	98.8%	CN¥80.1b	CN¥65.08	27.9	28.3%	0.6%	Materials
	600988	CN¥40.98	0.3%	64.3%	CN¥75.4b	CN¥48.09	21.5	21.3%	0.8%	Materials
	000975	CN¥26.48	9.3%	43.5%	CN¥73.4b	CN¥41.30	20.0	32.2%	1.8%	Materials
	002558	CN¥28.77	-4.3%	1.1%	CN¥54.5b	CN¥46.35	21.9	22.5%	1.3%	Media
	688578	CN¥117.31	5.6%	30.9%	CN¥52.8b	n/a	21.9	13.8%	1.0%	Pharmaceuticals & Biotech
	603979	CN¥74.58	-5.2%	36.7%	CN¥46.5b	CN¥80.95	18.5	20.7%	0.9%	Materials
	603129	CN¥283.50	-5.0%	3.9%	CN¥43.5b	CN¥334.66	25.9	27.2%	1.5%	Consumer Durables
	688188	CN¥103.05	-4.2%	8.5%	CN¥41.8b	CN¥113.67	35.6	21.5%	1.8%	Tech
	688213	CN¥98.49	8.8%	1.2%	CN¥39.6b	CN¥132.00	37.8	28.4%	1.0%	Semiconductors
	689009	CN¥44.88	6.2%	-27.2%	CN¥32.4b	CN¥58.78	21.2	31.0%	3.7%	Automobiles
	603606	CN¥39.02	-1.9%	-8.3%	CN¥32.1b	CN¥57.98	23.5	26.5%	1.2%	Capital Goods
	600301	CN¥49.50	4.3%	95.9%	CN¥31.3b	n/a	37.8	28.1%	0.8%	Materials
	688617 New	CN¥216.00	0.5%	-27.3%	CN¥30.5b	CN¥320.95	35.2	22.2%	0.5%	Healthcare
	603766	CN¥13.48	-7.5%	-0.07%	CN¥27.7b	CN¥20.56	17.2	23.4%	5.2%	Automobiles
	600499	CN¥14.42	-0.7%	23.7%	CN¥27.5b	CN¥26.00	17.7	27.2%	2.1%	Capital Goods
	688278	CN¥59.36	3.1%	-31.8%	CN¥24.2b	CN¥80.00	23.9	24.3%	1.0%	Pharmaceuticals & Biotech

Page 1 of 1